Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (AJMC®). She joined AJMC® in 2013 and is the primary staff editor for Evidence-Based Oncology, the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for AJMC®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for AJMC readers.
Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on LinkedIn.
Oklahoma Joins List of Red States Eyeing Medicaid Expansion
Governor Mary Fallin's proposal to embrace Medicaid expansion and fund the state share with a cigarette tax comes nearly a year after HHS Secretary Sylvia Burwell made an explicit appeal to work with governors in conservative states.
In Louisiana, Working to Expand Medicaid - Without Losing Other Programs
Officials are using innovative methods like automatically enrolling beneficiaries based on their eligibility for foods stamps, and adding a large group that takes part in an existing New Orleans-area health project but currently lacks prescription drug coverage.
5 Things to Know About Hepatitis C Screening and Treatment
As CDC reports a record number of deaths from hepatitis C, it seeks to raise awareness of the need for screening and treatment. Authors and the editor of a special issue of The American Journal of Managed Care will take part in a briefing on the issue.
UnitedHealthcare, Medtronic Deal Sparks Reaction From Those With Type 1 Diabetes
Exclusivity deals in managed care to hold down the cost of drug therapy are not new. But requiring persons with type 1 diabetes to use insulin pumps from a single manufacturer has brought out a whole different reaction.
Rival PCSK9 Makers Cut Prices to Get Approval from UK Health Service
Even though prices for both drugs in Britain was less than half the list price in the United States, NICE demanded further discounts before issuing a draft guidance that the therapies were appropriate for those who cannot otherwise lower cholesterol.
Deaths From Hepatitis C Virus Hit All-Time High, CDC Reports
CDC also published a separate study that found more people in the United States now die from hepatitis C than die from HIV or any other infectious disease. The report comes as The American Journal of Managed Care publishes a special issue on policy concerns over patient access to new therapies that cure HCV.